- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Fluid and Biopsy Based Biomarkers in Parkinson’s Disease ; volume:20 ; number:4 ; day:3 ; month:5 ; year:2023 ; pages:932-954 ; date:7.2023
Neurotherapeutics ; 20, Heft 4 (3.5.2023), 932-954, 7.2023
- Creator
-
Coughlin, David G.
Irwin, David J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13311-023-01379-z
- URN
-
urn:nbn:de:101:1-2023110610422631038586
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Coughlin, David G.
- Irwin, David J.
- SpringerLink (Online service)
Other Objects (12)
Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson’s disease diagnosis
Novel biomarkers and neuroimaging techniques in Parkinson’s disease
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy
A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson’s disease
Non-invasive electrophysiological biomarkers of aging and Parkinson’s disease
A systematic review of biomarkers for disease progression in Parkinson’s disease
Cerebrospinal Fluid Levels of Autophagy-related Proteins Represent Potentially Novel Biomarkers of Early-Stage Parkinson’s Disease
Inflammatory microbes and genes as potential biomarkers of Parkinson’s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
MRI biomarkers of freezing of gait development in Parkinson’s disease
Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson’s disease diagnosis
Novel biomarkers and neuroimaging techniques in Parkinson’s disease
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy
A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson’s disease
Non-invasive electrophysiological biomarkers of aging and Parkinson’s disease
A systematic review of biomarkers for disease progression in Parkinson’s disease
Cerebrospinal Fluid Levels of Autophagy-related Proteins Represent Potentially Novel Biomarkers of Early-Stage Parkinson’s Disease
Inflammatory microbes and genes as potential biomarkers of Parkinson’s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
MRI biomarkers of freezing of gait development in Parkinson’s disease
Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson’s disease diagnosis
Novel biomarkers and neuroimaging techniques in Parkinson’s disease
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy
A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson’s disease
Non-invasive electrophysiological biomarkers of aging and Parkinson’s disease
A systematic review of biomarkers for disease progression in Parkinson’s disease
Cerebrospinal Fluid Levels of Autophagy-related Proteins Represent Potentially Novel Biomarkers of Early-Stage Parkinson’s Disease
Inflammatory microbes and genes as potential biomarkers of Parkinson’s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition